Data on enfortumab vedotin plus pembrolizumab for advanced bladder cancer, along with updates on antibody-drug conjugates, biomarkers, and other cancer treatments, will be highlighted at the American ...
Levee Medical announced today that it closed its Series B financing, bringing in proceeds of more than $14 million.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback